Tobramycin Administered at the Beginning of Dialysis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions

Renal DialysisRenal Failure, Chronic

Interventions

DRUG

Tobramycin

5 milligrams per kilogram intravenous for one dose

Trial Locations (1)

Maisonneuve-Rosemont Hospital, Montreal

All Listed Sponsors

lead

Maisonneuve-Rosemont Hospital

OTHER

NCT03904836 - Tobramycin Administered at the Beginning of Dialysis | Biotech Hunter | Biotech Hunter